Background Thalassemia is the most common hereditary haemolytic anaemia in the world, including in Indonesia. The main treatment for thalassemia is regular transfusions, but these are known to cause iron overload. Moreover, iron overload in -thalassemia patients generates oxygen free radicals and peroxidative lipid injury. Ferritin serum concentration is used as indirect measurement of iron overload. Malondialdehyde (MDA), a terminal compound of lipid peroxidation, is used as an index of oxidative stress status.
T halassemia is the most common hereditary chronic hemolytic anaemia in the world, including in Indonesia. Thalassemia and hemoglobinopathies are caused by impaired synthesis of -or -globin chains. The number of thalassemia patients in Indonesia has increased. 4 registered at the Thalassemia Centre, Department of Child Health, Cipto Mangunkusumo Hospital (DCH-CMH), Jakarta. 5 -thalassemia major often receive regular blood transfusions, leading to iron overload. Excess iron deposits in tissues and organs are known to generate oxygen free radicals, which then react tissue injury is detectable in these patients, and results in damage and failure of organs. An abundance of free radicals requires an optimal antioxidant system to persist in thalassemia patients. The level of cellular antioxidant vitamins, such as vitamin A, C, and E, were found to be considerably lower in thalassemic patients compared to normal subjects.
These results suggest major antioxidant consumption in thalassemic patients with iron overload from continuous blood transfusions or oxidative stress. storage. MDA, a terminal compound of lipid peroxidation, is used widely as an index of oxidative status. Increased plasma MDA levels have been observed in patients affected by -thalassemia major. This substrate also causes cell damage and death, or genetic mutations. 24 This study was aimed to assess the correlation between iron overload and MDA as a marker of oxidative stress in thalasemia major patients.
Methods
This cross-sectional study was performed in the outpatient clinic at the Thalassemia Centre, DCH-CMH, Jakarta in sampling of thalassemia major patients. The inclusion criteria comprised of children diagnosed with thalassemia times or had been given iron-chelation treatment. Thalassemia major patients with acute or chronic infection, including hepatitis B or C, or hypersplenism were excluded. Based on the calculated required sample years in age. Informed consent was obtained from all of the participants/parents and the study was approved by the Ethics Committee of the University of Indonesia iron chelating agent consumption was collected by questionnaire and medical records. 25 Blood sample was analyzed for serum lipid peroxide by quantitative assay of MDA using thiobarbituric acid reactive substances at the Biochemistry Laboratory of the CMH, Jakarta. 26 The serum ferritin quantitative test was based on a solid phase enzyme-linked immunosorbent assay, using CMH, Jakarta. 
Results
Fifty-five subjects diagnosed with -thalassemia major were consecutively recruited for this study. Characteristics of the subjects are presented in Table 1 .
The mean MDA level of all subjects in this in Figure 1 .
Older subjects had higher MDA levels than younger subjects as shown in Table 2 . Homozygous ß-thalassemia subjects had higher MDA levels than deferasirox as an iron-chelating agent, had a length malnourished also had higher levels of MDA than subjects in other categories. Table 4 shows the bivariate analysis of the above variables with MDA level. 
Discussion
The mean of age at first transfusion of our subjects was et al. reported the age In contrast, most of our subjects were diagnosed later, since thalassemia screening is not routinely conducted in Indonesia. Consequently, blood transfusions would be received later.
In our study, 25 (45.5%) subjects were underon MUAC. Constantoulakis et al. reported that low body weight and growth impairment in ß-thalassemia major patients can be caused by various factors, such as chronic and severe anemia, enlarged spleen, and coexistence of other diseases, especially infections. The most common type of iron-chelating agent consumption adherence is typically better than others.
used iron-chelating agents regularly. This figure was higher than that from the Thalassemia Center, DCH- Malondialdehyde is a marker to determine the existence of oxidative stress. 24 We did not compare MDA levels of thalassemia patients to normal controls. A study on MDA levels in the normal Jakarta nmol/mL. In comparison, the mean MDA similar to a previous study that showed increased MDA in thalassemia major subjects compared to normal subjects. This situation can be explained by there being lipid peroxidation processing by auto-oxidation of unstable hemoglobin in thalassemia patients, with -chain producing radical peroxide (O 2 -), erythrocyterich iron, catalyst-like copper, and iron overload that make an oxidative stress condition.
Mean MDA level in thalassemia major subjects in this study was lower than in previous studies. This lower mean MDA may have been due to our use of homozygous ß-thalassemia and ß-thalassemia/HbE subjects, while other studies used normal control subjects.
We found the mean MDA level in nmol/mL, lower than that of homozygous ß-thalassemia result differs from a study by Goswami et al that showed MDA levels in homozygous ß-thalassemia subjects This condition was thought to be due to iron-binding by protein, thus free radical products were not increased.
There was no correlation between MDA level and by Livrea et al, Cighetti et al, 23 and Naithani et al, possibly due to different characteristics of the subjects. Their studies all used only homozygous ß-thalassemia subjects. Furthermore, existence of other factors such as age, type of iron-chelating agent, adherence to ironchelating agent consumption, adherence to vitamin E consumption, and nutritional status, could influence the results. As presented in Table 3 , homozygous ß-thalassemia subjects had a higher level of MDA than ß-thalassemia/HbE subjects, but also had lower level of serum ferritin, probably because homozygous ß-thalassemia subjects had a younger mean age, shorter length of disease, and better nutritional status than thalassemia-ß/HbE subjects. In addition, the majority of the homozygous ß-thalassemia subjects used deferiprone. Free iron may act as a catalyst to form reactive oxygen species by Fenton reaction. However, free iron-measurement (non-transferrin-bound iron) is not a routine examination in thalassemia patients.
body iron, and is not a measurement of free iron. This examination is relatively easy to do and inexpensive.
iron-content, although its value can be influenced by infection, inflammation, diet, nutritional status, liver disease, and diurnal variation.
The regularity of vitamin E consumption subjects might be caused by increased consumption as a consequence of oxidative stress and pressure on erythrocyte and other organs due to hemochromatosis. Liver damage induced by iron is related to the lack of lipid antioxidants. Mahjoub et al and Das et al reported that MDA level decreased in thalassemia subjects who received vitamin E.
There was also no correlation between nutritional MDA level, but MDA level has been correlated to malnourishment. Khaled et al stated that insufficient nutritional substances increased oxidative stress. 34 Nutritional substances that play a part in the free radical reaction process include vitamin E, vitamin A, vitamin C, selenium, zinc, manganese, copper, and ß-carotene. These substances act in enzymatic reactions. Malnourished children usually lack those nutritional substances. 35 plasma zinc levels in thalassemia subjects to be low, although there was only a weak correlation between plasma zinc level and nutritional status. 35 There were several limitations in this study.
As such, it was difficult to recruit subjects based on age group, gender, and other variables in balanced proportion to each other. Data on adherence to iron-chelating agent and vitamin E consumption was memories, which may be subjective and prone to recall bias. We conclude that the mean MDA level was was no correlation between MDA and ferritin serum correlation between consumption of iron-chelating revealed no correlation between adherence to vitamin as well as no correlation between nutritional status
